Vaccination Coverage by Age 24 Months Among Children Born in 2019 and 2020 - National Immunization Survey-Child, United States, 2020-2022.


Journal

MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429

Informations de publication

Date de publication:
03 Nov 2023
Historique:
medline: 6 11 2023
pubmed: 2 11 2023
entrez: 2 11 2023
Statut: epublish

Résumé

National Immunization Survey-Child data collected in 2022 were combined with data from previous years to assemble birth cohorts and assess coverage with routine vaccines by age 24 months by birth cohort. Overall, vaccination coverage was similar among children born during 2019-2020 compared with children born during 2017-2018, except that coverage with both the birth dose of hepatitis B vaccine and ≥1 dose of hepatitis A vaccine increased. Coverage was generally higher among non-Hispanic White (White) children (2-21 percentage points higher than coverage for non-Hispanic Black or African American, Hispanic or Latino, and non-Hispanic American Indian/Alaska Native [AI/AN] children), children living at or above poverty (3.5-22 percentage points higher than coverage for children living below the federal poverty level), privately insured children (2.4-38 percentage points higher than coverage for children with Medicaid, other insurance, or no insurance), and children in urban areas (3-16.5 percentage points higher than coverage for children living in rural areas). Coverage with the full series of Haemophilus influenzae type b conjugate vaccine was lower among AI/AN children compared with White children. Trends in vaccination coverage disparities across categories of race and ethnicity, health insurance status, poverty status, and urbanicity were evaluated for the 2016-2020 birth cohorts. Fewer than 5% of 168 trends examined were statistically significant, including six increases (widening of the coverage gap) and one decrease (narrowing of the gap). Analyses revealed a widening of the gap between children living at or above the poverty level (higher coverage) and those living below poverty (lower coverage), for several vaccines. Socioeconomic, demographic, and geographic disparities in vaccination coverage persist; addressing them is important to ensure protection for all children against vaccine-preventable disease.

Identifiants

pubmed: 37917561
doi: 10.15585/mmwr.mm7244a3
pmc: PMC10629749
doi:

Substances chimiques

Vaccines, Conjugate 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1190-1196

Déclaration de conflit d'intérêts

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Références

Vaccine. 2020 Nov 10;38(48):7596-7602
pubmed: 33071004
Acad Pediatr. 2021 May-Jun;21(4S):S1-S2
pubmed: 33958085
Vaccine. 2021 Jun 29;39(29):3983-3990
pubmed: 34059372
Curr Opin Pediatr. 2020 Feb;32(1):151-159
pubmed: 31790027
MMWR Morb Mortal Wkly Rep. 2023 Jan 13;72(2):33-38
pubmed: 36634013
Health Equity. 2021 Mar 16;5(1):135-139
pubmed: 33778316
MMWR Suppl. 2014 Apr 18;63(1):7-12
pubmed: 24743661
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S443-S451
pubmed: 34590134
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):234-237
pubmed: 35176011

Auteurs

Holly A Hill (HA)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

David Yankey (D)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

Laurie D Elam-Evans (LD)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

Michael Chen (M)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

James A Singleton (JA)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH